Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Signaling Pathways

Items 611-620 of 9364

Page
per page
  1. AXL1717
    A3209 AXL1717
    Target: Insulin-like growth factor receptors(IGFRs)
    Summary: IGF-1R inhibitor,orally active
      ≥20.7 mg/mL
  2. AZ20
    A3210 AZ20
     1 Citation
    Target: ATM/ATR
    Summary: ATR inhibitor,potent and selective
      ≥20.65 mg/mL
  3. AZD1152
    A3214 AZD1152
     1 Citation
    Target: Aurora Kinases
    Summary: Aurora B kinase inhibitor,highly potent and selective
      insoluble in H2O; insoluble in EtOH; ≥5.88 mg/mL
  4. AZD7687
    A3215 AZD7687
    Target: DGAT
    Summary: DGAT inhibitor,potent and selective
      Soluble in DMSO
  5. Balaglitazone
    A3216 Balaglitazone
    Summary: PPAR-γ partial agonist
      insoluble in H2O; ≥15.45 mg/mL
  6. Balapiravir
    A3217 Balapiravir
    Summary: Polymerase inhibitor,anti-HCV
      Soluble in DMSO
  7. BAM7
    A3218 BAM7
    Summary: BAX activator,direct and selective
      soluble in DMSO
  8. BAN ORL 24
    A3219 BAN ORL 24
    Summary: NOP receptor antagonist, potent and selective
      Soluble in DMSO
  9. Bardoxolone
    A3220 Bardoxolone
    Target: COX|iNOS
    Summary: Once-a-day treatment for CKD
      ≥49.2 mg/mL
  10. Bardoxolone methyl
    A3221 Bardoxolone methyl
    Target: Nrf2
    Summary: IKK inhibitor, potent antioxidant inflammation modulator
      ≥25.3 mg/mL

Items 611-620 of 9364

Page
per page